• COVID-19
  • Allergies and Infant Formula
  • Pharmacology
  • Telemedicine
  • Drug Pipeline News
  • Influenza
  • Allergy, Immunology, and ENT
  • Autism
  • Cardiology
  • Emergency Medicine
  • Endocrinology
  • Adolescent Medicine
  • Gastroenterology
  • Infectious disease
  • Nutrition
  • Neurology
  • Obstetrics-Gynecology & Women's Health
  • Developmental/Behavioral Disorders
  • Practice Improvement
  • Gynecology
  • Respiratory
  • Dermatology
  • Diabetes
  • Mental Health
  • Oncology
  • Psychiatry
  • Animal Allergies
  • Alcohol Abuse
  • Rheumatoid Arthritis
  • Sexual Health
  • Pain

Most parents support random performance-enhancing drug tests in high school

Article

Three out of four parents support random testing of high school athletes for performance-enhancing drugs, but less than half believe there should be individual penalties for those who test positive, according to C.S. Mott Children's Hospital's National Poll on Children's Health.

Three out of four parents support random testing of high school athletes for performance-enhancing drugs, but less than half believe there should be individual penalties for those who test positive, according to C.S. Mott Children's Hospital's National Poll on Children's Health.

The poll results, released November 17, also show that nearly one out of ten parents of a high school athlete knows someone under 18 who has tried performance-enhancing drugs.

The findings come from a nationally representative household survey administered in August 2008 that include 332 parents with high school athletes.

Other statistics include:

  • 57% of parents have talked with their children about performance-enhancing drugs.


  • 97% of parents believe that high school coaches should be required to communicate the dangers of performance-enhancing drugs.


  • 76% of parents believe schools should be required to report the number and percentage of positive tests to the state.


  • 43% believe individual names of athletes of who test positive should be reported.
Related Videos
Donna Hallas, PhD, CPNP, PPCNP-BC, PMHS, FAANP, FAAN
Scott Ceresnak, MD
Scott Ceresnak, MD
Importance of maternal influenza vaccination recommendations
Reducing HIV reservoirs in neonates with very early antiretroviral therapy | Deborah Persaud, MD
Samantha Olson, MPH
Deborah Persaud, MD
Ari Brown, MD, FAAP | Pediatrician and CEO of 411 Pediatrics; author, baby411 book series; chief medical advisor, Kabrita USA.
© 2024 MJH Life Sciences

All rights reserved.